Healthcare — FDA Pressures 2,200+ Companies on Trial Transparency; Medi-Cal Loses ~100K Immigrant Enrollees; AI Heart Screening Faces Reimbursement Questions

Healthcare · 2026-04-15

TODAY'S SIGNAL — Three distinct forces are reshaping healthcare operations simultaneously. First, the FDA is flexing enforcement muscle by notifying more than 2,200 companies and researchers of their obligation to report clinical trial results or face fines — a transparency push that will ripple through pharma and biotech compliance departments. Second, immigration policy is now a measurable…